Dr. Wenjing Li is a cancer researcher with a PhD in Chemical Genomics from Peking University Shenzhen Graduate School, China. Her predoctoral research focused on investigating receptor tyrosine kinases and their role in tumorigenesis through biochemical and molecular cell biology. She earned her B.S. in Biology from Ningxia University, China. Previously, Dr. Li was a Postdoctoral Fellow at the University of California, San Diego, where she studied ROR2 function and antibody treatment in breast cancer. Currently, she is a Postdoctoral Fellow at the University of Texas Health San Antonio, under the mentorship of Dr. Weixing Zhao. Her research focuses on the BRCA1-BARD1 ubiquitin E3 ligase activity, BRCA2-dependent R-loop resolution, and homologous recombination in genome maintenance and tumor suppression.